We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$50.8B
AUM Growth
-$294M
(-0.58%)
Cap. Flow
-$328M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$255M |
| 2 |
Textron
TXT
|
+$206M |
| 3 |
AstraZeneca
AZN
|
+$164M |
| 4 |
ExxonMobil
XOM
|
+$124M |
| 5 |
Moderna
MRNA
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$962M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$204M |
| 3 |
Devon Energy
DVN
|
+$201M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$170M |
| 5 |
Carrier Global
CARR
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.3% |
| 2 | Healthcare | 15.98% |
| 3 | Financials | 14.49% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Match Group
MTCH
$8.9B
| $46.6M | 0.09% |
296,696
+246,696
| +493% | +$37.6M |
|
227
Moody's
MCO
$83.8B
| $46.5M | 0.09% |
130,854
-45,300
| -26% | -$17.1M |
|
228
Synopsys
SNPS
$76.7B
| $46M | 0.09% |
153,600
-12,400
| -7% | -$3.76M |
|
229
RTX Corp
RTX
$300B
| $46M | 0.09% |
+534,570
| New | +$45.7M |
|
230
Simon Property Group
SPG
$72.9B
| $45.6M | 0.09% |
350,863
-5,100
| -1% | -$664K |
|
231
O'Reilly Automotive
ORLY
$76.3B
| $45.2M | 0.09% |
1,110,000
-261,000
| -19% | -$10.4M |
|
232
Teradyne
TER
$60.9B
| $44.7M | 0.09% |
409,124
+229,500
| +128% | +$27.9M |
|
233
Patria Investments
PAX
$1.83B
| $44.6M | 0.09% |
2,732,451
+242,100
| +10% | +$3.94M |
|
|
BNY
234
Bank of New York Mellon
BNY
$108B
| $44.4M | 0.09% |
856,716
+12,800
| +2% | +$665K |
|
235
OneMain Financial
OMF
$7.54B
| $44.4M | 0.09% |
802,018
+49,991
| +7% | +$2.91M |
|
236
Fox Class A
FOXA
$24.6B
| $44M | 0.09% |
1,096,584
+740,800
| +208% | +$27.3M |
|
|
IMGN
237
DELISTED
Immunogen Inc
IMGN
| $43.9M | 0.09% |
7,750,000
+750,000
| +11% | +$4.33M |
|
238
Marriott International
MAR
$94.2B
| $43.5M | 0.09% |
293,625
+7,700
| +3% | +$1.07M |
|
239
Electronic Arts
EA
$52.9B
| $43.4M | 0.09% |
305,221
-5,830
| -2% | -$818K |
|
240
Digital Realty Trust
DLR
$72.1B
| $43.2M | 0.09% |
299,000
+25,600
| +9% | +$4.02M |
|
241
Cadence Design Systems
CDNS
$92.8B
| $43M | 0.08% |
283,900
-17,800
| -6% | -$2.71M |
|
242
Aptiv
APTV
$9.95B
| $42.9M | 0.08% |
288,100
-79,200
| -22% | -$12.3M |
|
243
Sempra
SRE
$55.3B
| $42.6M | 0.08% |
673,970
-9,800
| -1% | -$647K |
|
244
State Street
STT
$51.4B
| $42.6M | 0.08% |
502,732
+34,400
| +7% | +$2.99M |
|
245
Fortinet
FTNT
$120B
| $42.3M | 0.08% |
724,090
+42,000
| +6% | +$2.43M |
|
246
Trane Technologies
TT
$106B
| $42M | 0.08% |
243,280
-5,266
| -2% | -$1.01M |
|
247
Everest Group
EG
$14.3B
| $41.9M | 0.08% |
166,910
-55,600
| -25% | -$14.3M |
|
248
Agilent Technologies
A
$39.9B
| $41.6M | 0.08% |
264,283
-254,700
| -49% | -$41.2M |
|
249
Ross Stores
ROST
$81.2B
| $41.4M | 0.08% |
380,686
-5,835
| -2% | -$699K |
|
250
Travere Therapeutics
TVTX
$5.84B
| $41.2M | 0.08% |
1,700,000
-1,893,763
| -53% | -$34.8M |
|
Similar funds
Adage Capital Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
- Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
- Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
- Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
- Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
- Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
- Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.
Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.